Pharmaceutical veteran Les Leff joins the TruTag board of directors

 TruTag Technologies, a leading security and technology solution provider, is pleased to announce that Les Leff of Polar Investment Fund – as well as the former co-owner and executive vice president of JWS Delavau Co, Inc., and former president of AccuCorp, contract manufacturers of vitamins, minerals and over-the-counter pharmaceuticals – is joining TruTag’s board of directors.

Prior to leading both JWS Delavau Co, Inc. and AccuCorp to a successful buyout in 2002, Mr. Leff served in a variety of senior technical liaison, plant management, union negotiation and Food and Drug Administration negotiation roles. He also directed the design and engineering of a state-of-the-art manufacturing facility. He currently leads Polar’s investment in technology, wellness and chemical businesses.

“I am excited to have the opportunity to contribute to this dynamic company,” said Mr. Leff. “I have every confidence that as soon as TruTag’s technologies are adopted, innovative changes will occur throughout the industry.”

“Les is a seasoned pharmaceutical executive with many years of leadership in this dynamic marketplace,” said Michael Bartholomeausz, chief executive officer of TruTag Technologies. “He brings a wealth of experience and operational knowledge that will help push TruTag forward as we expand our footprint in improving the safety, traceability, and authenticity of pharmaceuticals.”

Check Also

TraceParts and SnapEDA Partner to Offer Unified UX to Source Free PCB Footprints, Schematic Symbols & 3D MCAD Models

Today TraceParts, a provider of 3D digital content for engineering, and SnapEDA, the creators of …